Orange Book product · Generic (ANDA)
SITAGLIPTIN PHOSPHATE
SITAGLIPTIN PHOSPHATE
Generic (ANDA)ANDA 202387TE ABRX SANDOZ
At a glance
Jan 14, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 14, 2026
5 mo ago
Today
Pharmaceutical detail
Active ingredient
SITAGLIPTIN PHOSPHATE
Strength
EQ 25MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 202387
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SITAGLIPTIN PHOSPHATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
